Multiple sclerosis management has increasingly shifted from simply controlling acute relapses to preventing insidious neurodegeneration. In this evolving landscape, paramagnetic rim lesions have emerged as critical neuroimaging biomarkers reflecting chronic active neuroinflammation. Although clinicians widely recognize these lesions on susceptibility-sensitive magnetic resonance imaging, long-term prognostic evidence regarding their role in progressive neurological decline has remained limited. A robust longitudinal study published in Neurology offers definitive clinical insights. The investigation confirms that iron-rimmed compartmentalized inflammatory lesions substantially drive progression independent of relapse activity over five years of follow-up.

Understanding Chronic Active Inflammation and Paramagnetic Rim Lesions

Multiple sclerosis pathophysiology encompasses both acute focal demyelination and continuous, smoldering neuroinflammation. Acute lesions typically demonstrate blood-brain barrier breakdown, gadolinium enhancement, and subsequent partial remyelination. In contrast, chronic active lesions harbor a quiescent, hypocellular core encircled by a dynamic edge of iron-laden microglia and macrophages. Consequently, susceptibility-weighted imaging and quantitative susceptibility mapping visualize these specific edges as hypointense rings, establishing them as paramagnetic rim lesions.

These rimmed structures represent compartmentalized, smoldering inflammation behind an intact blood-brain barrier. Because standard immunomodulatory therapies primarily suppress peripheral leukocyte infiltration into the central nervous system, they often fail to arrest this localized microglial activation. Therefore, persistent iron rims continue to promote ongoing axonal transection, progressive demyelination, and localized tissue destruction. Recognizing these lesions allows clinicians to look beyond conventional T2 lesion counts. Identifying chronic active inflammation enables a more refined stratification of patients who are vulnerable to silent neurological decline despite apparent clinical stability.

Study Design and Deep Learning Segmentation on Susceptibility MRI

To evaluate the true prognostic impact of these radiological markers, researchers conducted a comprehensive longitudinal analysis within a large, ongoing single-center cohort. The study cohort comprised 862 individuals with multiple sclerosis, displaying a mean age of 40.3 years and a 64.7% female predominance. Investigators acquired high-resolution susceptibility-sensitive MRI scans at baseline to reconstruct quantitative susceptibility mapping datasets.

Subsequently, the researchers applied an advanced deep learning segmentation model to detect and quantify paramagnetic rim lesions accurately across all baseline scans. Expert neuroimaging specialists visually reviewed and validated all automated segmentations to ensure absolute anatomic plausibility. Among the overall cohort, 395 participants (45.8%) exhibited at least one confirmed paramagnetic rim lesion at baseline. The investigators followed 801 participants longitudinally over a median clinical duration of 5.1 years. They rigorously monitored clinical trajectories using the Expanded Disability Status Scale to systematically capture confirmed disability accumulation and distinguish relapse-associated worsening from relapse-independent progression.

Key Findings: Long-Term Disability and Progression Independent of Relapse Activity

During the five-year observation window, 142 of 801 longitudinally monitored patients (17.7%) experienced confirmed disability accumulation. Notably, 104 of these 142 progression events (73.2%) occurred entirely as progression independent of relapse activity, commonly termed PIRA. This observation underscores that non-relapse clinical worsening represents the dominant mode of permanent neurological decline in contemporary treated cohorts.

Multivariable Cox proportional hazards regression models revealed that the baseline presence of paramagnetic rim lesions conferred an 80% higher risk of experiencing PIRA (adjusted hazard ratio [aHR] 1.8, 95% confidence interval [CI] 1.1–2.8; p = 0.02). Furthermore, sensitivity analyses demonstrated that this prognostic hazard remained consistent across diverse clinical subgroups. Neither baseline diagnostic category, prior disability accrual rates, nor disease-modifying therapy choices during follow-up attenuated this elevated risk. Thus, the presence of persistent iron rims stands out as an independent, robust radiological predictor of insidious disability accumulation.

Biological Correlates: Intrathecal Inflammation and Brain Atrophy

Beyond tracking clinical disability scores, the researchers conducted exploratory analyses investigating parallel biological markers. First, they evaluated cerebrospinal fluid profiles obtained during clinical workups. Patients harboring paramagnetic rim lesions displayed significantly higher indices of chronic intrathecal humoral immune activation and elevated inflammatory biomarkers. This correlation confirms that visible imaging rims mirror genuine underlying compartmentalized neuroinflammation.

Second, the investigators evaluated longitudinal structural brain changes by computing the annual percentage brain volume change. Patients with higher numbers of paramagnetic rim lesions exhibited accelerated rates of global brain atrophy over time (PBVC: beta = -0.012%, 95% CI -0.018% to -0.005%). This finding indicates that smoldering rim activity drives both focal axonal injury and diffuse cerebral neurodegeneration. Therefore, the presence of persistent microglial rims directly connects chronic active inflammatory foci with accelerated parenchymal volume loss.

Translating Imaging Biomarkers into Routine Neurological Practice

These clinical findings carry immediate therapeutic implications for neurodegenerative disease management. Historically, clinicians evaluated therapeutic success primarily by counting new or enlarging T2 lesions and monitoring clinical relapses. However, patients demonstrating zero relapse activity may still experience relentless progression driven by chronic active lesions. Incorporating quantitative susceptibility mapping into routine 3-Tesla MRI protocols allows neurologists to identify high-risk individuals early.

Moreover, recognizing the burden of smoldering inflammation provides an objective rationale for selecting specialized high-efficacy disease-modifying agents or considering emerging therapies that cross the blood-brain barrier, such as Bruton tyrosine kinase inhibitors. In clinical trial designs, paramagnetic rim lesions can serve as valuable enrichment biomarkers to recruit individuals with active smoldering pathology. Ultimately, integrating advanced susceptibility neuroimaging into everyday neurological workflows empowers clinicians to anticipate disability accrual, tailor individual surveillance intervals, and deliver proactive neuroprotective management strategies.

Frequently Asked Questions

What are paramagnetic rim lesions in multiple sclerosis?

Paramagnetic rim lesions are chronic active brain lesions characterized by a central core of demyelination surrounded by an iron-rich peripheral rim of activated microglia and macrophages. These distinctive rims appear as dark hypointense rings on susceptibility-weighted MRI scans and reflect compartmentalized, low-grade smoldering inflammation.

How do paramagnetic rim lesions influence patient prognosis?

The presence of baseline paramagnetic rim lesions nearly doubles the long-term risk of progression independent of relapse activity over a five-year period. Furthermore, patients with these lesions experience increased markers of intrathecal inflammation and accelerated annual rates of global brain volume loss.

Can conventional MRI sequences detect these chronic active lesions?

Conventional T1 and T2 fluid-attenuated inversion recovery sequences cannot reliably distinguish paramagnetic rims because they lack phase sensitivity. Clinicians require susceptibility-weighted imaging, quantitative susceptibility mapping, or T2*-weighted sequences on high-field scanners (typically 3 Tesla) to visualize the iron rim morphology accurately.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with qualified healthcare professionals. Refer to the latest local and national guidelines for clinical practice.

References

1. Lauerer M et al. The Prognostic Value of Paramagnetic Rim Lesions in People With Multiple Sclerosis. Neurology. 2026 Sep 22. doi: 10.1212/WNL.0000000000218428. PMID: 42623573.

2. Absinta M, Sati P, Masuzzo F, et al. Association of Chronic Active Multiple Sclerosis Lesions With Disability in Vivo. JAMA Neurol. 2019;76(12):1474-1483. doi:10.1001/jamaneurol.2019.2399.

3. Maggi P, Kuhle J, Schädelin S, et al. Chronic Active Lesions in Multiple Sclerosis: Biology, Imaging, and Clinical Significance. Lancet Neurol. 2024;23(4):412-424.